Try a single issue or save on a subscription Issues delivered straight to your door or device ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Treatment and management of CompSA can be complex. Diagnosis can also be challenging due to similarities in symptoms. While they have different causes and risk factors, all types of sleep apnea ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

Sleep Apnea Contributes to Dementia in Older Adults ... 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination ...

The Let’s Talk Smiles podcast announces its upcoming episode on sleep-related health issues, featuring sleep expert and ...